Ardizzoni A - Search Results

1

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.

Facchinetti F, Tiseo M, Gnetti L, Silini EM, Ardizzoni A. Facchinetti F, et al. Among authors: ardizzoni a. Lung Cancer. 2013 Oct;82(1):177-8. doi: 10.1016/j.lungcan.2013.07.018. Epub 2013 Aug 13. Lung Cancer. 2013. PMID: 23953757 No abstract available.

2

Camptothecin analogues in the treatment of non-small cell lung cancer.

Ardizzoni A. Ardizzoni A. Lung Cancer. 1995 Apr;12 Suppl 1:S177-85. doi: 10.1016/0169-5002(95)00434-3. Lung Cancer. 1995. PMID: 7551927 Review.

3

Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines.

Loprevite M, Favoni RE, de Cupis A, Pirani P, Pietra G, Bruno S, Grossi F, Scolaro T, Ardizzoni A. Loprevite M, et al. Among authors: ardizzoni a. Lung Cancer. 2001 Jul;33(1):27-39. doi: 10.1016/s0169-5002(00)00247-6. Lung Cancer. 2001. PMID: 11429193

4

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

Cappuzzo F, Ardizzoni A, Soto-Parra H, Gridelli C, Maione P, Tiseo M, Calandri C, Bartolini S, Santoro A, Crinò L. Cappuzzo F, et al. Among authors: ardizzoni a. Lung Cancer. 2003 Aug;41(2):227-31. doi: 10.1016/s0169-5002(03)00189-2. Lung Cancer. 2003. PMID: 12871787 Clinical Trial.

5

Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.

Tiseo M, Loprevite M, Ardizzoni A. Tiseo M, et al. Among authors: ardizzoni a. Curr Med Chem Anticancer Agents. 2004 Mar;4(2):139-48. doi: 10.2174/1568011043482106. Curr Med Chem Anticancer Agents. 2004. PMID: 15032719 Review.

6

Predictors of clinical response of non-small cell cancer to gefitinib.

Ardizzoni A, Tiseo M. Ardizzoni A, et al. JAMA. 2004 Apr 7;291(13):1563; author reply 1563-4. doi: 10.1001/jama.291.13.1563-a. JAMA. 2004. PMID: 15069041 No abstract available.

7

Complete spontaneous remission of non-small-cell lung cancer: a case report.

Cafferata MA, Chiaramondia M, Monetti F, Ardizzoni A. Cafferata MA, et al. Among authors: ardizzoni a. Lung Cancer. 2004 Aug;45(2):263-6. doi: 10.1016/j.lungcan.2004.01.026. Lung Cancer. 2004. PMID: 15246199

8

Induction chemotherapy with carboplatin-paclitaxel followed by standard radiotherapy with concurrent daily low-dose cisplatin plus weekly paclitaxel for inoperable non-small-cell lung cancer.

Ardizzoni A, Scolaro T, Mereu C, Cafferata MA, Tixi L, Bacigalupo A, Tiseo M, Monetti F, Rosso R. Ardizzoni A, et al. Am J Clin Oncol. 2005 Feb;28(1):58-64. doi: 10.1097/01.coc.0000139486.24747.26. Am J Clin Oncol. 2005. PMID: 15685036 Clinical Trial.

9

Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

Ardizzoni A, Tiseo M. Ardizzoni A, et al. J Chemother. 2004 Nov;16 Suppl 4:104-7. doi: 10.1179/joc.2004.16.Supplement-1.104. J Chemother. 2004. PMID: 15688623 Review.

10

CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma.

Tiseo M, Monetti F, Ferrarini M, Serrano J, Chiaramondia M, Ardizzoni A. Tiseo M, et al. Among authors: ardizzoni a. J Clin Oncol. 2005 Mar 1;23(7):1578-9. doi: 10.1200/JCO.2005.03.115. J Clin Oncol. 2005. PMID: 15735133 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters